在COVID-19间歇性肺病 (ENDCOV-I) 中早期的宁泰达尼布部署:随机,双盲,安慰剂控制试验的研究协议
Valeria Santibanez1, Aditi Mathur2, Jigna Zatakia3
1Icahn School of Medicine at Mount Sinai, New York, New York, USA valeria.santibanez@jefferson.edu.
BMJ open respiratory research
|April 11, 2025
概括
这项研究调查了宁泰达尼布是否可以预防COVID-19幸存者的纤维化肺病进展. 随机试验将在180天内评估肺功能变化和死亡率.
科学领域:
- 肺部病理学 肺部病理学
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
背景情况:
- 由于COVID-19大流行引起了广泛的肺炎,幸存者面临慢性纤维化肺病的风险.
- 丁丁达尼布是一种氨酸激酶抑制剂,对渐进性纤维性肺病有效.
- 有限的数据存在于Nintedanib在COVID-19后的肺损伤中的有效性.
研究的目的:
- 评估nintedanib在预防COVID-19幸存者的肺损伤进展方面的潜力.
- 评估宁泰达尼布对肺功能和死亡率在这个患者子组的影响.
主要方法:
- 一个多中心,随机,双盲,安慰剂受控试验.
- 大约有170名COVID-19后患有亚急性肺损伤的患者随机分配给宁泰达尼布或安慰剂.
- 主要终点:180天后强迫生命能力 (FVC) 的变化;次要终点包括扩散能力,6分钟步行测试和死亡率.
主要成果:
- 结果正在等待患者随访和数据分析的完成.
- 该研究旨在检测FVC变化和其他关键临床结果的显著差异.
结论:
- 宁达达尼布可能提供一种治疗策略,以减轻COVID-19幸存者的长期呼吸道并发症.
- 需要进一步的研究来确认宁泰达尼布在管理COVID-19肺部后续症的作用.
相关概念视频
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...


